FILE PHOTO: A healthcare professional prepares a dose of AstraZeneca (COVID-19) vaccine at the Narok County Referral Hospital, in Narok, Kenya, December 1, 2021. REUTERS/Baz Ratner
BRUSSELS/LONDON (Reuters) -The relatively short shelf life of AstraZeneca Plc's COVID-19 vaccine is complicating the rollout to the world's poorest nations, according to officials and internal World Health Organization documents reviewed by Reuters.
It is the latest headache to plague the COVAX vaccine-sharing project, co-led by the WHO and aimed at getting shots to the world's neediest people.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
